29.10.2021 • NewsWacker

Wacker Takes Majority Stake in China Silane Firm

German chemical company Wacker has acquired a 60% stake in Chinese specialty silane producer SICO Performance Material for an undisclosed sum. The transaction is expected to close in the first half of 2022 once the necessary regulatory and antitrust approvals have been received.

SICO Performance Material produces a range of organo-functional silanes at the Jining New Material Industrial Park in Shandong province. The silanes are used in the construction, automotive, semiconductor and electronics industries. Regarded as one of China’s leading silane suppliers, the company generated sales of €54 million in 2020.

"Our new partnership with SICO is a consistent step in our strategy to further expand the share of high-margin specialties in our silicone business worldwide," said Wacker’s president and CEO Christian Hartel. "By acquiring a stake in SICO, we are now further expanding our range of high-performance specialty products in Asia and moving closer to our customers in these fast-growing consumer markets."

Prior to buying the stake in SICO, Wacker has manufactured organofunctional silanes exclusively in Germany. The Munich-based multinational group added that it will finance the investment from its free cashflow.

Author: Elaine Burridge, Freelance Journalist

German chemical company Wacker has acquired a 60% stake in Chinese specialty...
German chemical company Wacker has acquired a 60% stake in Chinese specialty silane producer SICO Performance Material for an undisclosed sum. The transaction is expected to close in the first half of 2022 once the necessary regulatory and antitrust approvals have been received. (c) Wacker

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read